EGFR Positive Lung Cancer UK’s Post

💊 Cellular immunotherapies are offering new hope in the fight against diseases like cancer, particularly for patients who have exhausted conventional treatments. 💡With promising clinical outcomes and a surge in regulatory approvals, the sector is experiencing rapid growth and constant innovation. 📈 As a result, various therapy modalities are under exploration for a range of indications, showcasing the dynamic nature of this field. 📸 Here's a snapshot of some of the most popular therapeutic modalities, the cells they utilise, and their target cell recognition mechanisms. This list serves as a glimpse into the current market landscape, highlighting the ongoing advancements in cellular immunotherapy. #Immunotherapy #CellTherapy #CancerResearch #TCRT #cellularimmunotherapy #ImmunoOncology #CancerTreatment #PrecisionMedicine

New issue online!📝 #Transcriptomics-based #liquidbiopsy panel for early non-invasive identification of peritoneal recurrence and #micrometastasis in locally advanced #gastriccancer ------ This study by Zhao et al. aimed to develop a novel six-gene expression biomarker panel to enhance the early detection and risk stratification of peritoneal recurrence and micrometastasis in locally advanced gastric cancer (LAGC). For free👇 https://lnkd.in/densgFeP #GastricCancer #TranscriptomicsPanel IFO - Istituto Nazionale Tumori Regina Elena - Istituto Dermatologico San Gallicano

 ncRNAs are the most studied blood-based diagnostic biomarkers in patients with GC because of their abundance, stability, widespread circulation, and tumor-specific expression.  It has been reported that the diagnostic value of the three-miRNA signature panel (miR 627, miR-629, and miR-652) was significantly higher in patients with GC than in healthy participants, with 86.7% sensitivity, 85.5% specificity, and 0.941 AUC. #liquidbiopsy #gastriccancer #miRNA #ncRNA #rnaseq #blood #cancerresearch 📚 Liquid Biopsy: An Emerging Diagnostic, Prognostic, and Predictive Tool in Gastric Cancer

Historically, autoimmune and cancer treatments have relied on one-size-fits-all solutions, which haven't had good outcomes for so many patients. There is, therefore, a great need for personalised cancer treatment options that can meet every patient's needs. One such initiative is the In Vitro Diagnostic (IVD) that Pierian Biosciences is currently developing. It will help with the creation of affordable patient-specific treatments that will improve outcomes. Want a further discussion on this? Contact us using the details provided on the page in this link 👉: https://heyor.ca/5wVrOm #PersonalisedCancerTreatment #InVitroDiagnostic #IVD #PierianBiosciences

Historically, autoimmune and cancer treatments have relied on one-size-fits-all solutions, which haven't had good outcomes for so many patients. There is, therefore, a great need for personalised cancer treatment options that can meet every patient's needs. One such initiative is the In Vitro Diagnostic (IVD) that Pierian Biosciences is currently developing. It will help with the creation of affordable patient-specific treatments that will improve outcomes. Want a further discussion on this? Contact us using the details provided on the page in this link 👉: https://heyor.ca/5wVrOm #PersonalisedCancerTreatment #InVitroDiagnostic #IVD #PierianBiosciences

Biomarker-informed treatment planning has expanded possibilities for people with #ColorectalCancer, especially those with metastatic disease. Biomarker test results can provide insight into a patient’s cancer type, predicted tumor response to specific treatment, dosing decisions, and more. ➡️ Discover how biomarker testing works: https://lnkd.in/g8F5uuYw

GC Cell recently conducted an in-house seminar that underscored the vital significance of early detection of #Hepatocellular_Carcinoma (HCC) and the role of #Cytokine_Induced_Killer (CIK) cell therapy as an #adjuvant_treatment regimen to deter HCC recurrence. To reduce the risk of #recurrence, the National Cancer Center advocates for CIK adjuvant therapy following curative treatment. This approach has gained recognition in esteemed publications, including NCCN, Lancet, and various other journals. Staying informed and proactive is key to advancing liver cancer care. #HepatocellularCarcinoma #cancerprevention #medicaladvancements #liver #cytokines #tcells #NKcell #cellthrapy #tcell

#WEBINARWEDNESDAY ALERT: On Wednesday, October 2, 2024, Dr. El Ahmar will present groundbreaking research on predictive biomarkers of response and resistance to immunotherapy. This webinar will dive deep into the spatial distribution of these biomarkers within the tumor microenvironment of renal cell carcinoma. 🕒 Time: 8:00 AM PST | 11:00 AM EST Register now and mark your calendars! https://lnkd.in/dm6mMQPE #Immunotherapy #RenalCellCarcinoma #DigitalPathology #WebinarWednesday #LeicaBiosystems #CancerResearch For Research Use Only.

Explore the future of lung cancer diagnostics with expert insights! These short videos define essential concepts and discuss cutting-edge developments in biomarker testing. #LungCancer #Biomarkers Watch now: https://ow.ly/5nae50QOIFs